Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Stocks

Biotechs Looking Up – Two Stocks To Take Advantage

by January 24, 2025
January 24, 2025
Biotechs Looking Up – Two Stocks To Take Advantage

The Biotech industry group is making a comeback and the ‘under the hood’ chart displays new strength coming into the group. We have a constructive bottom that price is breaking from and while it does need to overcome resistance at the 200-day EMA, it looks encouraging. What impressed was the increase in participation of stocks above key moving averages which is trending higher. A positive close today would likely see these numbers expand.

The Silver Cross Index measures how many stocks have a 20-day EMA greater than the 50-day EMA, or those stocks holding a “Silver Cross”. The Silver Cross Index is moving swiftly higher right now and should see a Bullish Shift across the signal line soon.

We will say that this is a rather aggressive group so it could turn on us should the market weaken. Stay nimble.

I did a quick scan and found two stocks in this area that you might find interesting.

First we have a stock that I picked yesterday for DP Diamonds subscribers. In DP Diamonds I go through my scan results and find the best candidates to present to subscribers. I give out ten stock and ETF picks per week. PTCT has broken from a declining trend. The RSI is positive and the PMO is rising toward a Crossover BUY Signal. Stochastics are also on the rise. Notice relative strength studies. The group is attempting to outperform again. PTCT is outperforming both the group and the SPY. I’ve opted to set the stop as close to support as possible without making it too deep. There is plenty of upside potential here.

VERV is breaking out from an intermediate-term trading channel. I like this breakout move. It is trying very hard to close above resistance. Given the positive RSI and rising PMO above the zero line on a Crossover BUY Signal, it looks like this breakout will materialize. The OBV broke out with price so the rally is being confirmed. Stochastics are above 80. Relative strength is excellent for VERV against both the group and the SPY. We could see a little profit taking at this resistance level, but that would likely offer a good entry.

Conclusion: Biotechs are rallying and under the hood indicators are confirming the rise. We should see more upside out of this group, but as noted earlier, this is an aggressive group and will likely require the market to continue making its way higher. Should the market turn on us, there won’t be too many areas that will be unscathed, but for now the rally is holding up.

The DP Alert: Your First Stop to a Great Trade!

Before you trade any stock or ETF, you need to know the trend and condition of the market. The DP Alert gives you all you need to know with an executive summary of the market’s current trend and condition. It not only covers the market! We look at Bitcoin, Yields, Bonds, Gold, the Dollar, Gold Miners and Crude Oil! Only $50/month! Or, use our free trial to try it out for two weeks using coupon code: DPTRIAL2. Click HERE to subscribe NOW!

Learn more about DecisionPoint.com:

Watch the latest episode of the DecisionPointTrading Room on DP’s YouTube channel here!

Try us out for two weeks with a trial subscription!

Use coupon code: DPTRIAL2 Subscribe HERE!

Technical Analysis is a windsock, not a crystal ball. –Carl Swenlin

(c) Copyright 2025 DecisionPoint.com

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional. Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.

DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. DecisionPoint newsletters, blogs or website materials should NOT be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.

Helpful DecisionPoint Links:

Trend Models

Price Momentum Oscillator (PMO)

On Balance Volume

Swenlin Trading Oscillators (STO-B and STO-V)

ITBM and ITVM

SCTR Ranking

Bear Market Rules

0
FacebookTwitterGoogle +Pinterest
previous post
Executive Order on Digital Assets and Financial Technology Is a Great Start
next post
Patel, Gabbard to appear before Senate committees next week

You may also like

Small-caps Break Out and Lead – Now What?

July 19, 2024

Gold Rushed by a Wave of Economic Data

March 7, 2023

A Day in the Life of a Trader

April 12, 2023

Growth Stocks Shine in Short-Covering Rally

August 29, 2023

When Will the Stock Market’s Bullish Momentum Snap?...

July 10, 2024

Fasten Your Seatbelts: Earnings Season in the Spotlight

July 7, 2023

Sector Spotlight: Keep An Eye; This Could Be...

January 9, 2023

Market Timing for a Rule-Based Strategy

September 9, 2024

How to Create Your Own Custom Multi-Timeframe Chart...

December 2, 2022

Which Cyber Security ETF is the Strongest?

September 28, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump confirms 2 nuclear submarines are ‘in the region’ to counter Russia

      August 4, 2025
    • Trump Accounts Won’t Replace Social Security or Help Americans Build Significant Wealth

      August 4, 2025
    • How Special Interests Keep Bad Laws on the Books: The Case of the Jones Act

      August 4, 2025
    • Four Cymru partners with Wales Tech Week to showcase Welsh innovation on the global stage

      August 4, 2025
    • Rachel Reeves urged to apply VAT to private healthcare in bid to fund NHS

      August 4, 2025
    • Trump accuses Senate Democrats of using nominee confirmations as leverage for funding deals

      August 4, 2025

    Categories

    • Business (8,658)
    • Investing (2,170)
    • Politics (16,294)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved